MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site

We examined the MLL translocation in two cases of infant AML with X chromosome disruption. The G-banded karyotype in the first case suggested t(X;3)(q22;p21)ins(X;11)(q22;q13q25). Southern blot analysis showed one MLL rearrangement. Panhandle PCR approaches were used to identify the MLL fusion transcript and MLL genomic breakpoint junction. SEPTIN6 from chromosome band Xq24 was the partner gene of MLL. MLL exon 7 was joined in-frame to SEPTIN6 exon 2 in the fusion transcript. The MLL genomic breakpoint was in intron 7; the SEPTIN6 genomic breakpoint was in intron 1. Spectral karyotyping revealed a complex rearrangement disrupting band 11q23. FISH with a probe for MLL confirmed MLL involvement and showed that the MLL-SEPTIN6 junction was on the der(X). The MLL genomic breakpoint was a functional DNA topoisomerase II cleavage site in an in vitro assay. In the second case, the karyotype revealed t(X;11)(q22;q23). Southern blot analysis showed two MLL rearrangements. cDNA panhandle PCR detected a transcript fusing MLL exon 8 in-frame to SEPTIN6 exon 2. MLL and SEPTIN6 are vulnerable to damage to form recurrent translocations in infant AML. Identification of SEPTIN6 and the SEPTIN family members hCDCrel and MSF as partner genes of MLL suggests a common pathway to leukaemogenesis.

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .

[3]  H. Alder,et al.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.

[4]  Michael L. Cleary,et al.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.

[5]  P. Nowell,et al.  Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Greaves,et al.  In utero rearrangements in the trithorax-related oncogene in infant leukaemias , 1993, Nature.

[7]  C. Croce,et al.  Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Rowley,et al.  Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Caligiuri,et al.  ALL-1 partial duplication in acute leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Tse,et al.  A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. , 1995, Blood.

[11]  A. Hagemeijer,et al.  The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. , 1995, Blood.

[12]  F. Mitelman.  ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .

[13]  F. Behm,et al.  Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins. , 1995, Medical and pediatric oncology.

[14]  J. Buckley,et al.  Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. , 1996, Blood.

[15]  D. Ledbetter,et al.  Multicolor Spectral Karyotyping of Human Chromosomes , 1996, Science.

[16]  T. Rabbitts,et al.  An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.

[17]  J. Cooper,et al.  Septins may form a ubiquitous family of cytoskeletal filaments , 1996, The Journal of cell biology.

[18]  C. Caldas,et al.  EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Housman,et al.  MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Roe,et al.  Identification of complex genomic breakpoint junctions in the t(9;11) MLL‐AF9 fusion gene in acute leukemia , 1997 .

[21]  Y. Hayashi,et al.  The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. , 1997, Blood.

[22]  Y. Hayashi,et al.  Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). , 1997, Blood.

[23]  Arndt Borkhardt,et al.  Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23) , 1997, Oncogene.

[24]  R Greim,et al.  Exon/intron structure of the human AF‐4 gene, a member of the AF‐4/LAF‐4/FMR‐2 gene family coding for a nuclear protein with structural alterations in acute leukaemia , 1997, British journal of haematology.

[25]  R. Berger,et al.  AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. , 1997, Blood.

[26]  M. Greaves,et al.  Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Veldman,et al.  Spectral karyotyping, a 24-colour FISH technique for the identification of chromosomal rearrangements , 1997, Histochemistry and Cell Biology.

[28]  M. Cleary,et al.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL , 1997, The EMBO journal.

[29]  P. Nowell,et al.  MLL Genomic Breakpoint Distribution Within the Breakpoint Cluster Region in De Novo Leukemia in Children , 1998, Journal of pediatric hematology/oncology.

[30]  R. Stallard.  The AGT Cytogenetics Laboratory Manual, 3rd ed, Margaret J Barch, Turid Knutsen, Jack L Spurbeck (Eds.). Lippincott-Raven Publishers, Philadelphia (1997), 666, with illus, $135, (telephone: 800-777-2295), ISBN: 0-397-51651-7 , 1998 .

[31]  E. Rappaport,et al.  t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Johansson,et al.  Ten novel 11q23 chromosomal partner sites , 1998, Leukemia.

[33]  J. Rowley,et al.  The critical role of chromosome translocations in human leukemias. , 1998, Annual review of genetics.

[34]  J. Ross.  Maternal diet and infant leukemia: A role for DNA topoisomerase II inhibitors? , 1998, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[35]  S. Nakazawa,et al.  Acute myeloid leukemia with hypergranular cytoplasm accompanied by t(X;11)(q24;q23) and rearrangement of the MLL gene. , 1999, Leukemia research.

[36]  P. Nowell,et al.  Duplicated regions of AF-4 intron 4 at t(4;11) translocation breakpoints. , 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[37]  B. Freidlin,et al.  Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  M. Osaka,et al.  MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Borkhardt,et al.  A DNA damage repair mechanism is involved in the origin of chromosomal translocations t(4;11) in primary leukemic cells , 1999, Oncogene.

[40]  Y. Hayashi,et al.  AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Kellogg,et al.  Septins: cytoskeletal polymers or signalling GTPases? , 1999, Trends in cell biology.

[42]  Y. Hayashi,et al.  AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25). , 1999, Cancer research.

[43]  U. Jaeger,et al.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Deléage,et al.  AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14) , 2000, Oncogene.

[45]  M. Kinoshita,et al.  Differential localization of septins in the mouse brain , 2000, The Journal of comparative neurology.

[46]  K. Sano,et al.  Novel SH3 protein encoded by the AF3p21 gene is fused to the mixed lineage leukemia protein in a therapy-related leukemia with t(3;11) (p21;q23). , 2000, Blood.

[47]  Changchun Du,et al.  Chromatin‐related properties of CBP fused to MLL generate a myelodysplastic‐like syndrome that evolves into myeloid leukemia , 2000, The EMBO journal.

[48]  M. Caligiuri,et al.  Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Felix,et al.  Pediatric Acute Lymphoblastic Leukemia: Challenges and Controversies in 2000. , 2000, Hematology. American Society of Hematology. Education Program.

[50]  P. Nowell,et al.  Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Nowell,et al.  Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  N. Osheroff,et al.  Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. , 2000, Progress in nucleic acid research and molecular biology.

[53]  C. Lavau,et al.  Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Nowell,et al.  t(3;11) translocation in treatment-related acute myeloid leukemia fuses MLL with the GMPS (GUANOSINE 5' MONOPHOSPHATE SYNTHETASE) gene. , 2000, Blood.

[55]  S. Bojesen,et al.  The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A Brizard,et al.  Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23) , 2001, Genes, chromosomes & cancer.

[57]  A. Borkhardt,et al.  An ins(X;11)(q24;q23) fuses the MLL and the Septin 6/KIAA0128 gene in an infant with AML‐M2 , 2001, Genes, chromosomes & cancer.

[58]  P. Nowell,et al.  Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  W. Trimble,et al.  Expression and analysis of properties of septin CDCrel-1 in exocytosis. , 2001, Methods in enzymology.

[60]  T. Taki,et al.  The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines , 2001, Genes, chromosomes & cancer.

[61]  M. Greaves,et al.  GPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24) , 2001, Genes, chromosomes & cancer.

[62]  J. Horiguchi-Yamada.  Transcription Factors: Normal and Malignant Development of Blood Cells , 2001, International journal of hematology.

[63]  Y. Hayashi,et al.  SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24. , 2002, Cancer research.

[64]  J. Potter,et al.  Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group , 1996, Cancer Causes & Control.